American Cancer Society

Kayla A. Craig, DNP, FNP-BC, RN, is recognized by Continental Who's Who

Retrieved on: 
Thursday, December 1, 2022

EDWARDSVILLE, Ill., Dec. 1, 2022 /PRNewswire/ -- Kayla A. Craig, DNP, FNP-BC, RN, is being recognized by Continental Who's Who as an Exceptional Healthcare Provider in the medical field for her excellence as a Family Nurse Practitioner.

Key Points: 
  • EDWARDSVILLE, Ill., Dec. 1, 2022 /PRNewswire/ -- Kayla A. Craig, DNP, FNP-BC, RN, is being recognized by Continental Who's Who as an Exceptional Healthcare Provider in the medical field for her excellence as a Family Nurse Practitioner.
  • Dr. Craig attended Southern Illinois University in Edwardsville and earned her nursing degree prior to graduating with her Doctor of Nursing Practice degree from the same academic institution.
  • She is a board-certified family nurse practitioner currently serving patients in Belleville, IL, where she specializes in urgent care practice.
  • She has experience in family medicine, pediatric home care, oncology, and telemetry.

PGT Innovations shows support for four breast cancer non-profits with donation totaling over $9,000

Retrieved on: 
Thursday, December 1, 2022

PGT Innovations (NYSE: PGTI), a leading manufacturer of premium windows, doors, and garage doors, recently donated over $9,000 across four breast cancer non-profits.

Key Points: 
  • PGT Innovations (NYSE: PGTI), a leading manufacturer of premium windows, doors, and garage doors, recently donated over $9,000 across four breast cancer non-profits.
  • PGT Innovations team members across the companys multiple manufacturing plant and office locations purchased over 1,100 t-shirts, raising a total of $8,155.50, which was then donated between the Breast Cancer Research Foundation , the Breast Cancer Alliance , and the Larry Fitzgerald Foundation .
  • Our organization was founded on three core values: serving, leading, and thriving, said Jeff Jackson, PGT Innovations President and CEO.
  • PGT Innovations also donated $1,500 to the American Cancer Society in support of the Making Strides Against Breast Cancer walk event held in Sarasota, FL in mid-October, and several PGTI team members showed their support by participating in the walk.

Cancer Diagnostics Global Market Report 2022: Lifestyle Shifts Increasing Prevalence of Cancer and Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 1, 2022

The global cancer diagnostics market size is expected to reach USD 293.5 billion by 2030., expanding at a CAGR of 6.89% from 2022 to 2030.

Key Points: 
  • The global cancer diagnostics market size is expected to reach USD 293.5 billion by 2030., expanding at a CAGR of 6.89% from 2022 to 2030.
  • Continual introduction of innovative products, coupled with increasing need for early diagnosis of various diseases, is a prime factor driving the market.
  • The demand for cancer diagnosis tools is significantly increasing worldwide due to technological advancements in the field of diagnosis.
  • Thus, rising prevalence of cancer globally is anticipated to create significantly boost the demand for diagnostic products during the forecast period.

New Study Published in MDPI Demonstrates Combination of Virtual Reality and Artificial Intelligence Reduces Hot Flashes and Improves Psychological Well-Being in Women

Retrieved on: 
Wednesday, November 30, 2022

BOSTON, Nov. 30, 2022 /PRNewswire/ --The results of a clinical trial using software from XRHealth, developer and operator of virtual treatment rooms in the metaverse, published in MDPI highlights that the combination of virtual reality and artificial intelligence reduces hot flashes and improves the overall psychological well-being of women with breast and ovarian cancer. 

Key Points: 
  • Female cancer survivors often experience hot flashes that can also cause difficulty sleeping and waking up with night sweats.
  • The study consisted of forty-two women, ranging in ages 25-60 that suffered from hot flashes and were receiving chemotherapy, endocrine therapy, or estrogen blocking anticancer treatment.
  • Patients were asked to self-report and assess hot flashes, psychiatric distress, illness perception, quality of sleep, and quality of life.
  • Patients reported a significant reduction in the frequency of hot flashes, stress, psychiatric distress, sleep difficulties, and quality of life.

ENT and Allergy Associates, LLP Board of Directors has selected Daniel Blum, MPA as its new Chief Executive Officer

Retrieved on: 
Tuesday, November 29, 2022

Tarrytown, New York, Nov. 29, 2022 (GLOBE NEWSWIRE) -- ENT and Allergy Associates, LLP (ENTA) the largest ENT, Allergy, and Audiology practice in the country is pleased to announce that Daniel Blum, MPA has been appointed as its new Chief Executive Officer, effective February 27, 2023.

Key Points: 
  • Tarrytown, New York, Nov. 29, 2022 (GLOBE NEWSWIRE) -- ENT and Allergy Associates, LLP (ENTA) the largest ENT, Allergy, and Audiology practice in the country is pleased to announce that Daniel Blum, MPA has been appointed as its new Chief Executive Officer, effective February 27, 2023.
  • Daniel Blum will succeed Robert Glazer who is stepping down from the CEO role after 25 years.
  • The Board is excited and looks forward to working with Dan and the senior management team to build on the companys momentum.
  • Dan is a thoughtful communicator and a resourceful and strategic-minded healthcare veteran with substantial experience working at the executive and board level.

IN-SHAPE RAISES $127K FOR CANCER RESEARCH

Retrieved on: 
Tuesday, November 29, 2022

The money raised will go to local chapters of the American Cancer Society and to St. Jude Childrens Research Hospital.

Key Points: 
  • The money raised will go to local chapters of the American Cancer Society and to St. Jude Childrens Research Hospital.
  • This additional $127,000 adds to the $576,000 In-Shape previously raised and donated for a total of $703,000.
  • The money raised will help local chapters of The American Cancer Society provide free cancer education and emotional support to those just diagnosed, free lodging for people with cancer and their caregivers while receiving treatment far from home, and many more services in communities close to In-Shape.
  • Funds will also support cutting-edge cancer research at a national level.

FlowPlay Surpasses $550,000 Milestone in Funds Raised for American Cancer Society

Retrieved on: 
Tuesday, November 29, 2022

SEATTLE, Nov. 29, 2022 /PRNewswire/ -- FlowPlay, creator of one of the most powerful connected gaming platforms, today announced its Vegas World in-game fundraisers have surpassed $550,000 raised for the American Cancer Society (ACS). This news comes on the heels of FlowPlay's most recent campaign, which raised $60,000 for ACS's Patient Navigation Program. FlowPlay also celebrates over one million charms sold for ACS, a major driver of overall fundraising.

Key Points: 
  • SEATTLE, Nov. 29, 2022 /PRNewswire/ -- FlowPlay , creator of one of the most powerful connected gaming platforms, today announced its Vegas World in-game fundraisers have surpassed $550,000 raised for the American Cancer Society (ACS).
  • In October, FlowPlay offered a virtual branded charm in the company's flagship connected game, Vegas World , which was available for players to purchase.
  • "The American Cancer Society is so grateful to FlowPlay, and specifically to Vegas World players, for their generous support of patient navigation, transportation, and other lifesaving programs for cancer patients," said Paula Aspiazu, Vice President, Community Impact, American Cancer Society.
  • To learn more about the American Cancer Society and how to donate, please visit: http://www.cancer.org .

EQS-News: Mainz Biomed Announces U.S. Extension of ColoFuture Study to Evaluate Integration of Novel mRNA Biomarkers into ColoAlert

Retrieved on: 
Sunday, November 27, 2022

ColoFuture/eAArly DETECT are multi-center studies assessing the potential of these biomarkers to identify advanced adenomas, a type of pre-cancerous polyp often attributed to CRC.

Key Points: 
  • ColoFuture/eAArly DETECT are multi-center studies assessing the potential of these biomarkers to identify advanced adenomas, a type of pre-cancerous polyp often attributed to CRC.
  • Five novel gene expression (mRNA) biomarkers were in-licensed from the Universit de Sherbrooke, Quebec, Canada, in early January 2022.
  • In the institutions pioneering work, researchers tested a battery of novel transcriptional biomarkers using colon cancer samples and precancerous lesions.
  • The five mRNA targets chosen by Mainz Biomed provided the greatest sensitivity and specificity of detection (Herring et al.

Florida Cancer Specialists & Research Institute Supports American Cancer Society Guidelines for Colonoscopies

Retrieved on: 
Tuesday, November 22, 2022

Dr. Karen Knudsen, Chief Executive Officer at the American Cancer Society, shared in response to the study: Preventive cancer screenings are the best and most trusted way to save lives.

Key Points: 
  • Dr. Karen Knudsen, Chief Executive Officer at the American Cancer Society, shared in response to the study: Preventive cancer screenings are the best and most trusted way to save lives.
  • Thats why the American Cancer Society recommends colorectal cancer screening, including colonoscopy, for adults beginning at age 45.
  • About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
    Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida.
  • The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.

Florida Cancer Specialists & Research Institute Supports American Cancer Society Guidelines for Colonoscopies

Retrieved on: 
Tuesday, November 22, 2022

Dr. Karen Knudsen, Chief Executive Officer at the American Cancer Society, shared in response to the study: Preventive cancer screenings are the best and most trusted way to save lives.

Key Points: 
  • Dr. Karen Knudsen, Chief Executive Officer at the American Cancer Society, shared in response to the study: Preventive cancer screenings are the best and most trusted way to save lives.
  • Thats why the American Cancer Society recommends colorectal cancer screening, including colonoscopy, for adults beginning at age 45.
  • About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
    Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida.
  • The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.